CLDN18 and intrahepatic cholangiocarcinoma: However, despite a report suggesting upregulated CLDN18 (encompassing both isoforms) in ICC, the specific biological significance of CLDN18.2, including its associations with clinicopathological features, prognosis, and the tumor immune microenvironment (TIME), remains uncharacterized in ICC (17).